|
0
|
|
Pharmacokinetics/pharmacodynamics of ceftazidime-avibactam in critically ill adult patients receiving continuous renal replacement therapy.
(journals.asm.org)
|
Li C
…
Ge Y
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#dosing
#amr
#pharmacodynamics
#sepsis
|
|
0
|
|
Characterization of a novel monoclonal antibody candidate that targets bacterial GAPDH and protects neonatal mice from infections caused by Streptococcus pneumoniae or Streptococcus agalactiae.
(journals.asm.org)
|
Fernandes C
…
Castanheira P
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#infection
#virulence
#antibody
#immunotherapy
#sepsis
|
|
0
|
|
A short antimicrobial peptides family demonstrates efficacy to infection via a multimodal mechanism of action.
(journals.asm.org)
|
Liu Y
…
Ru S
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#virulence
#biofilm
#sepsis
#antimicrobial peptides
|
|
0
|
|
Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).
(journals.asm.org)
|
Bekker A
…
Cressey TR
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#amr
#sepsis
#neonatal
|